Business
HCW Biologics to Present at 2022 Virtual Growth Conference Sponsored by the Maxim Group and M-Vest
Founder and CEO, Hing C. Wong, Ph.D., to be guest at “Fireside Chat” MIRAMAR, Fla., March 24, 2022 (GLOBE NEWSWIRE) -- HCW Biologics Inc. (the “Company” or
About this update from Hcw Biologics Inc.
[{"type":"text","content":"Founder and CEO, Hing C. Wong, Ph.D., to be guest at “Fireside Chat”\nMIRAMAR, Fla., March 24, 2022 (GLOBE NEWSWIRE) -- HCW Biologics Inc. (the “Company” or “HCW Biologics”) (NASDAQ: HCWB), a biopharmaceutical company focused on discovering and developing novel immunotherapies to lengthen health span by disrupting the link between chronic, low-grade inflammation and age-related diseases, will participate in Maxim’s 2022 Virtual Growth Conference being held March 28 – 30, 2022. Members of the HCW Biologics’ management team will provide an overview of the Company highlighting the status of its internal pipeline, upcoming milestones for multiple clinical trials for difficult-to-treat cancer indications, and its clinical development strategy to expand to the treatment of other age-related diseases associated with the chronic state of inflammation known as “inflammaging.” The pre-recorded presentation will be available on demand to registered conference attendees. Presenters will include: Hing C. Wong, Ph.D., Founder and Chief Executive Officer; Peter Rhode, Ph.D., Chief Science Officer and Vice President of Clinical Operations; Rebecca Byam, Chief Financial Officer; and Nicole Valdivieso, Director of Legal Affairs. Dr. Wong will also be the guest at a fireside chat hosted by Jason McCarthy, Ph.D., Senior Managing Director and Head of Biotechnology Research at the Maxim Group, and Michael Okunewitch, Senior Analyst, Biotechnology Research at the Maxim Group, on Wednesday, March 30, at 8:30 a.m. E.T. Members of the Company’s management team will be available for one-on-one virtual meetings which can be coordinated through the Maxim Group. Fireside chat with Dr. Hing C. Wong: March 30, 2022, at 8:30 a.m. E.T. Corporate overview available on demand: March 28 – 30, 2022 Here is the RSVP link, which you can share with your colleagues: https://m-vest.com/events/2022-virtual-growth-conference *Please note this link will not be live until event begins About HCW Biologics:HCW Biologics is a transformative immunotherapy company that focuses on inflammaging, a state of unresolved inflammatory responses and chronic inflammation. The Company is developing novel immunotherapies designed to improve health span by disrupting the link between chronic, low-grade inflammation and age-related diseases such as cancer, cardiovascular diseases, diabetes, n...